Principal Financial Group Inc Trevena Inc Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.2 - $0.5 $3,343 - $8,357	-16,715 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$0.57 - $1.29 $19,858 - $44,942	-34,839 Reduced 67.58%	16,715 $10,000
Q3 2021 Nov 09, 2021	SELL	$1.11 - $1.7 $7,770 - $11,900	-7,000 Reduced 11.95%	51,554 $63,000
Q2 2021 Aug 10, 2021	BUY	$1.46 - $2.25 $42,792 - $65,947	29,310 Added 100.23%	58,554 $98,000
Q1 2021 May 10, 2021	BUY	$1.77 - $2.93 $3,640 - $6,027	2,057 Added 7.57%	29,244 $52,000
Q4 2020 Feb 08, 2021	BUY	$2.13 - $3.26 $57,908 - $88,629	27,187 New	27,187 $58,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $295M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.